Clinical Trials Directory

Trials / Unknown

UnknownNCT01070277

Antiparasitic Treatment for Returning Travelers With Chronic Diarrhea

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study hypotheses is that Antiparasitic therapy in patients with chronic diarrhea after travel to a developing country, with a negative stool findings, will be significantly effective in eliminating diarrhea and other gastro-intestinal complaints compared to similar patients receiving placebo.

Detailed description

It is common to encounter travelers from developing countries who suffer from persistent diarrhea after returning home. In many cases repeated stool samples are negative for bacteria, parasites and helminthes and the cause of the diarrhea is not found. The main debate is whether this condition is a persistent parasitic infection (unidentified) or post-infectious irritable bowel syndrome.However, clinical experience suggests that some of these travelers respond to antiparasitic therapy. This study aims to answer the question whether antiparasitic treatment in these cases is beneficial.

Conditions

Interventions

TypeNameDescription
DRUGTinidazole and AlbendazoleTinidazole 2 gr/daily for 2 days followed by Albendazole 400mg X2 /day for 7 days
DRUGPlacebo control2 placebo pills X2 /day for 2 days followed by 1 placebo Pill X2 / day for 7 days

Timeline

Start date
2012-03-01
Primary completion
2015-12-01
Completion
2016-12-01
First posted
2010-02-18
Last updated
2014-08-27

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT01070277. Inclusion in this directory is not an endorsement.